Jie Liu

A phase 1, open-label study of LCAR-B38M, a chimeric antigen receptor T cell therapy directed against B cell maturation antigen, in patients with relapsed or refractory multiple myeloma

Wanhong Zhao, Jie Liu, Baiyan Wang et al. · Journal of Hematology & Oncology · 2018 · 526 citations · Full text

Immunology, Immunodominance, Immunotherapeutics +19

CD47-blocking immunotherapies stimulate macrophage-mediated destruction of small-cell lung cancer

Kipp Weiskopf, Nadine S. Jahchan, Peter J. Schnorr et al. · Journal of Clinical Investigation · 2016 · 421 citations · Full text

Immune Evasion, Cd47-blocking Immunotherapies, Cancer Immunosurveillance +14

Antibody therapy targeting the CD47 protein is effective in a model of aggressive metastatic leiomyosarcoma

Badreddin Edris, Kipp Weiskopf, Anne Kathrin Volkmer et al. · Proceedings of the National Academy of Sciences · 2012 · 253 citations · Full text

Tumor-associated Macrophages, Immunology, Resident Macrophages +24

Four-year follow-up of LCAR-B38M in relapsed or refractory multiple myeloma: a phase 1, single-arm, open-label, multicenter study in China (LEGEND-2)

Wanhong Zhao, Baiyan Wang, Lijuan Chen et al. · Journal of Hematology & Oncology · 2022 · 139 citations · Full text

Plaque and tangle imaging and cognition in normal aging and Alzheimer's disease

Meredith N. Braskie, Andrea D. Klunder, Kiralee M. Hayashi et al. · Neurobiology of Aging · 2008 · 111 citations · Full text

Cognitive Science, Alzheimer's Disease, Aging +12